Mabura 40mg Injection contains adalimumab, a monoclonal antibody that blocks tumour necrosis factor-alpha (TNF-α) to reduce inflammation in autoimmune diseases.

Jakura 5mg Tablet contains tofacitinib, a Janus kinase (JAK) inhibitor that reduces inflammatory responses in autoimmune diseases.

Intajac Tablet contains tofacitinib, a Janus kinase inhibitor that suppresses inflammatory signalling in autoimmune disorders.

Intajac 5mg Tablet contains tofacitinib, a Janus kinase (JAK) inhibitor that reduces inflammation by blocking intracellular signalling pathways.

Intacept 50mg Injection contains etanercept, a recombinant TNF-alpha inhibitor that suppresses inflammation in autoimmune diseases.

Intacept 25mg Injection contains etanercept, a TNF-alpha inhibitor that reduces inflammation by blocking tumour necrosis factor.

Adlumab 40mg Injection contains adalimumab, a monoclonal antibody that blocks tumour necrosis factor-alpha (TNF-α), helping reduce inflammation and control immune-mediated diseases.

Adfrar 40mg Injection contains adalimumab, a monoclonal antibody that blocks tumour necrosis factor-alpha, helping reduce inflammation and immune-system activity in autoimmune diseases.